Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2425429
Max Phase: Preclinical
Molecular Formula: C36H42F3N5O8
Molecular Weight: 615.73
Molecule Type: Small molecule
Associated Items:
ID: ALA2425429
Max Phase: Preclinical
Molecular Formula: C36H42F3N5O8
Molecular Weight: 615.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCCO.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C34H41N5O6.C2HF3O2/c35-27(20-25-13-15-26(41)16-14-25)34(45)39-18-7-12-30(39)33(44)38-29(22-24-10-5-2-6-11-24)32(43)37-28(31(42)36-17-19-40)21-23-8-3-1-4-9-23;3-2(4,5)1(6)7/h1-6,8-11,13-16,27-30,40-41H,7,12,17-22,35H2,(H,36,42)(H,37,43)(H,38,44);(H,6,7)/t27-,28-,29-,30-;/m0./s1
Standard InChI Key: FWYDQVXTMOYUOM-IEGYNWRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 615.73 | Molecular Weight (Monoisotopic): 615.3057 | AlogP: 0.82 | #Rotatable Bonds: 14 |
Polar Surface Area: 174.09 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: 7.72 | CX LogP: 1.34 | CX LogD: 0.98 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.16 | Np Likeness Score: -0.13 |
1. Mollica A, Costante R, Stefanucci A, Pinnen F, Luisi G, Pieretti S, Borsodi A, Bojnik E, Benyhe S.. (2013) Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation., 68 [PMID:23974016] [10.1016/j.ejmech.2013.07.044] |
Source(1):